Hepatitis C Stocks

Description:

This portfolio consists of public companies that are researching a cure for Hepatitis C which affects 170 million people worldwide

"The hottest area in drug development right now and for the next couple of years is hepatitis C," said Kris Jenner, whow runs the $1.7 billion T. Rowe Price Health Sciences Fund.

Most Viewed Portfolios

View All

Articles

5 Rocket Stocks for Gluttonous Turkey Day Gains

11.24.14 | 07:56 AM

BALTIMORE ( Stockpickr) -- This Thanksgiving, have your turkey and mashed potatoes with a side of stock gains. It may sound surprising, but statist...

Time to Sell These 5 'Toxic' Stocks

11.21.14 | 11:27 AM

BALTIMORE ( Stockpickr) -- Which stocks should I buy? It's the eternal question that most investors spend most of their time wondering. But is it t...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter